Sialic acid and the central nervous system

Perspectives on biological functions, detection, imaging methods and manipulation

Srinivasa Gopalan Sampathkumar, Adrienne Li, Kevin J Yarema

Research output: Contribution to journalArticle

Abstract

Glycobiology, broadly defined as the study of sugars in living systems, is becoming increasingly important for understanding the basic biology of the central nervous system (CNS) and diagnosing and devising new treatments for neurological disorders. Decades of research have uncovered many roles for both glycolipids and glycoproteins in the proper functioning of the brain; moreover many diseases are characterized by abnormalities in either the biosynthesis or catabolism of these cellular components. In many cases, however, only a rudimentary understanding of the basic biological roles of sugars in neural function exists. Similarly, methods to detect and diagnose glycosylation disorders are far from state-of-the-art compared to many facets of modern medicine. This review focuses on sialic acid, arguably the most important monosaccharide in CNS, and describes how recent advances in its manipulation by chemical and metabolic methods hold the possibility to converge with advanced instrumentation such as magnetic resonance imaging, positron emission tomography, diffusion tensor imaging, and single photon emission computerized tomography now used for imaging of the CNS in human subjects. Specifically, methods are under development for tagging sialic acids in living systems with contrast agents suitable for magnetic resonance imaging, in essence allowing for the functional imaging of sugars at a molecular level. One of these methods, biochemical engineering of sialic acids by use of small molecule metabolic substrates, also holds promise for the manipulation of sialic acids for the development of novel therapies for neurological disorders.

Original languageEnglish (US)
Pages (from-to)425-440
Number of pages16
JournalCNS and Neurological Disorders - Drug Targets
Volume5
Issue number4
DOIs
StatePublished - Aug 2006

Fingerprint

N-Acetylneuraminic Acid
Sialic Acids
Central Nervous System
Nervous System Diseases
Magnetic Resonance Imaging
Glycomics
Modern 1601-history
Diffusion Tensor Imaging
Monosaccharides
Glycolipids
Single-Photon Emission-Computed Tomography
Glycosylation
Positron-Emission Tomography
Contrast Media
Glycoproteins
Brain
Research
Therapeutics

Keywords

  • Alzheimer's disease (AD)
  • Brain development
  • Cerebrospinal fluid
  • Gangliosides
  • Lectins
  • Neural cell adhesion molecule (NCAM)

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pharmacology

Cite this

Sialic acid and the central nervous system : Perspectives on biological functions, detection, imaging methods and manipulation. / Sampathkumar, Srinivasa Gopalan; Li, Adrienne; Yarema, Kevin J.

In: CNS and Neurological Disorders - Drug Targets, Vol. 5, No. 4, 08.2006, p. 425-440.

Research output: Contribution to journalArticle

@article{c4507bc423bc4dcebd17eec5c01cc1f2,
title = "Sialic acid and the central nervous system: Perspectives on biological functions, detection, imaging methods and manipulation",
abstract = "Glycobiology, broadly defined as the study of sugars in living systems, is becoming increasingly important for understanding the basic biology of the central nervous system (CNS) and diagnosing and devising new treatments for neurological disorders. Decades of research have uncovered many roles for both glycolipids and glycoproteins in the proper functioning of the brain; moreover many diseases are characterized by abnormalities in either the biosynthesis or catabolism of these cellular components. In many cases, however, only a rudimentary understanding of the basic biological roles of sugars in neural function exists. Similarly, methods to detect and diagnose glycosylation disorders are far from state-of-the-art compared to many facets of modern medicine. This review focuses on sialic acid, arguably the most important monosaccharide in CNS, and describes how recent advances in its manipulation by chemical and metabolic methods hold the possibility to converge with advanced instrumentation such as magnetic resonance imaging, positron emission tomography, diffusion tensor imaging, and single photon emission computerized tomography now used for imaging of the CNS in human subjects. Specifically, methods are under development for tagging sialic acids in living systems with contrast agents suitable for magnetic resonance imaging, in essence allowing for the functional imaging of sugars at a molecular level. One of these methods, biochemical engineering of sialic acids by use of small molecule metabolic substrates, also holds promise for the manipulation of sialic acids for the development of novel therapies for neurological disorders.",
keywords = "Alzheimer's disease (AD), Brain development, Cerebrospinal fluid, Gangliosides, Lectins, Neural cell adhesion molecule (NCAM)",
author = "Sampathkumar, {Srinivasa Gopalan} and Adrienne Li and Yarema, {Kevin J}",
year = "2006",
month = "8",
doi = "10.2174/187152706777950729",
language = "English (US)",
volume = "5",
pages = "425--440",
journal = "CNS and Neurological Disorders - Drug Targets",
issn = "1871-5273",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Sialic acid and the central nervous system

T2 - Perspectives on biological functions, detection, imaging methods and manipulation

AU - Sampathkumar, Srinivasa Gopalan

AU - Li, Adrienne

AU - Yarema, Kevin J

PY - 2006/8

Y1 - 2006/8

N2 - Glycobiology, broadly defined as the study of sugars in living systems, is becoming increasingly important for understanding the basic biology of the central nervous system (CNS) and diagnosing and devising new treatments for neurological disorders. Decades of research have uncovered many roles for both glycolipids and glycoproteins in the proper functioning of the brain; moreover many diseases are characterized by abnormalities in either the biosynthesis or catabolism of these cellular components. In many cases, however, only a rudimentary understanding of the basic biological roles of sugars in neural function exists. Similarly, methods to detect and diagnose glycosylation disorders are far from state-of-the-art compared to many facets of modern medicine. This review focuses on sialic acid, arguably the most important monosaccharide in CNS, and describes how recent advances in its manipulation by chemical and metabolic methods hold the possibility to converge with advanced instrumentation such as magnetic resonance imaging, positron emission tomography, diffusion tensor imaging, and single photon emission computerized tomography now used for imaging of the CNS in human subjects. Specifically, methods are under development for tagging sialic acids in living systems with contrast agents suitable for magnetic resonance imaging, in essence allowing for the functional imaging of sugars at a molecular level. One of these methods, biochemical engineering of sialic acids by use of small molecule metabolic substrates, also holds promise for the manipulation of sialic acids for the development of novel therapies for neurological disorders.

AB - Glycobiology, broadly defined as the study of sugars in living systems, is becoming increasingly important for understanding the basic biology of the central nervous system (CNS) and diagnosing and devising new treatments for neurological disorders. Decades of research have uncovered many roles for both glycolipids and glycoproteins in the proper functioning of the brain; moreover many diseases are characterized by abnormalities in either the biosynthesis or catabolism of these cellular components. In many cases, however, only a rudimentary understanding of the basic biological roles of sugars in neural function exists. Similarly, methods to detect and diagnose glycosylation disorders are far from state-of-the-art compared to many facets of modern medicine. This review focuses on sialic acid, arguably the most important monosaccharide in CNS, and describes how recent advances in its manipulation by chemical and metabolic methods hold the possibility to converge with advanced instrumentation such as magnetic resonance imaging, positron emission tomography, diffusion tensor imaging, and single photon emission computerized tomography now used for imaging of the CNS in human subjects. Specifically, methods are under development for tagging sialic acids in living systems with contrast agents suitable for magnetic resonance imaging, in essence allowing for the functional imaging of sugars at a molecular level. One of these methods, biochemical engineering of sialic acids by use of small molecule metabolic substrates, also holds promise for the manipulation of sialic acids for the development of novel therapies for neurological disorders.

KW - Alzheimer's disease (AD)

KW - Brain development

KW - Cerebrospinal fluid

KW - Gangliosides

KW - Lectins

KW - Neural cell adhesion molecule (NCAM)

UR - http://www.scopus.com/inward/record.url?scp=33746992102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746992102&partnerID=8YFLogxK

U2 - 10.2174/187152706777950729

DO - 10.2174/187152706777950729

M3 - Article

VL - 5

SP - 425

EP - 440

JO - CNS and Neurological Disorders - Drug Targets

JF - CNS and Neurological Disorders - Drug Targets

SN - 1871-5273

IS - 4

ER -